Mostrando 154,901 - 154,920 Resultados de 154,954 Para Buscar '"Take That"', tiempo de consulta: 0.80s Limitar resultados
  1. 154901
  2. 154902
    por Luo, Christine T, Yee, Jennifer
    Publicado 2020
    “…The goal of this scenario is to increase awareness of this critical diagnosis. Detailed history-taking to identify risk factors will aid in the recognition of spinal epidural abscesses. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  3. 154903
    “…TOPICS: Cyanide toxicity, carbon monoxide toxicity, cyanide antidote, fire victim, intubation, airway intervention, oxygen treatment, history taking, lab testing ordering, symptom identification, interpretation of lab results, emergency medicine simulation.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 154904
  5. 154905
    “…CENP-E itself is a kinetochore motor, which accumulates transiently at kinetochores in the G(2) phase of the cell cycle before mitosis takes place, appears to modulate chromosome movement and spindle elongation,and is degraded at the end of mitosis. …”
    Enlace del recurso
    Enlace del recurso
    Texto
  6. 154906
    “…AUTHORS' CONCLUSIONS: Although limited data were available, the analysis did not detect a difference in recurrence between the 7‐day regimen and the standard 14‐day regimen of 0.5 mg/kg/day primaquine, and no serious adverse events were reported in G6PD‐normal participants taking 0.5 mg/kg/day of primaquine. This shorter regimen may be useful in G6PD‐normal patients if there are treatment adherence concerns. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  7. 154907
    “…While student evaluations for the first cohort will be available end of the semester, true evaluation of TRI will be the number of trainees taking the course and successful grant proposal submissions. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 154908
  9. 154909
    “…Seroconversion of neutralising antibodies was seen for 109 (92%) of 118 participants in the 3 μg group, 117 (98%) of 119 in the 6 μg group, and two (3%) of 60 in the placebo group at day 14 after the days 0 and 14 schedule; whereas at day 28 after the days 0 and 28 schedule, seroconversion was seen in 114 (97%) of 117 in the 3 μg group, 118 (100%) of 118 in the 6 μg group, and none (0%) of 59 in the placebo group. INTERPRETATION: Taking safety, immunogenicity, and production capacity into account, the 3 μg dose of CoronaVac is the suggested dose for efficacy assessment in future phase 3 trials. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  10. 154910
    “…P4P refers to the transfer of money or material goods conditional on taking a measurable action or achieving a predetermined performance target. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 154911
    “…A secondary focus was on measures of personal and social skills, and risk behaviour (such as drug and alcohol use, violent behaviour, sexual risk taking). All study designs that used a well‐defined control group were eligible for inclusion. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  12. 154912
  13. 154913
    “…The results show that the direct effect model of positive academic emotion and negative academic emotion on online learning investment fits well (x2 = 61.06, X2 / DF = 2.91, CFI = 0.96, TLI = 0.94, RMSEA = 0.062, 90% CI = 0.050-0.091, SRMR = 0.046), and positive academic emotion (β = 0.42, t = 5.85, p<0.001) and negative academic emotions (β = - 0.35, t = -5.64, p<0.001) the standardized path coefficients of online learning investment are significant. Taking learning efficacy as an intermediary variable into the intermediary effect model, it can be found that the intermediary effect model reaches an excellent level, and the fitting index is x2 = 86 92,x 2 / d f = 2.48, CFI = 0.97, TLI = 0.97, RMSEA = 0.062, 90% CI = 0.046-0.079, SRMR= 0.044. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  14. 154914
    “…PARTICIPANTS/MATERIALS, SETTING, METHODS: Participants were US or Canadian women aged 18–40 and not pregnant, who were heterosexually active, without known subfertility and not taking exogenous hormones. Most of the women were intending to avoid pregnancy at the start of follow-up. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 154915
    por Knichel, Michael Linus
    Publicado 2016
    “…Spectra are normalized to inelastic yields and cross sections (pp), respectively non-single-diffractive yields (p–Pb), taking into account the efficiencies of the trigger and the vertex reconstruction. …”
    Enlace del recurso
  16. 154916
    por Woudstra, M J
    Publicado 2002
    “…Numerous Higgs particles will be produced at the LHC, if it exists at all, and its discovery should be possible after a few years of data taking. This thesis is devoted to ATLAS, one of the two general-purpose detectors at the LHC. …”
    Enlace del recurso
  17. 154917
    “…Unsurprisingly, perceived confidence in the medical management of toxicology patients improved for 87% (13/15) of respondents after having taken the course, with 2 respondents noting the same level of confidence before and after taking the course. Lastly, multiple residents wrote in the free-response section that the toxicology rotation had been directly helpful to them when managing various toxidromes with real cases in the emergency department. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 154918
    por Rush, Brian, Urbanoski, Karen
    Publicado 2019
    “…OBJECTIVE: System planners and funders encounter many challenges in taking action toward evidence-informed enhancement of substance use treatment systems. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  19. 154919
  20. 154920
    “…Informed consent from the patient (or legally authorized substitute decision maker). 1. pregnancy; 2. hemoglobin <80 g/L in the last 72 hours; 3. platelet count <50 x 10(9)/L in the last 72 hours; 4. known fibrinogen <1.5 g/L (if testing deemed clinically indicated by the treating physician prior to the initiation of anticoagulation); 5. known INR >1.8 (if testing deemed clinically indicated by the treating physician prior to the initiation of anticoagulation); 6. patient already prescribed intermediate dosing of LMWH that cannot be changed (determination of what constitutes an intermediate dose is to be at the discretion of the treating clinician taking the local institutional thromboprophylaxis protocol for high risk patients into consideration); 7. patient already prescribed therapeutic anticoagulation at the time of screening [low or high dose nomogram UFH, LMWH, warfarin, direct oral anticoagulant (any dose of dabigatran, apixaban, rivaroxaban, edoxaban)]; 8. patient prescribed dual antiplatelet therapy, when one of the agents cannot be stopped safely; 9. known bleeding within the last 30 days requiring emergency room presentation or hospitalization; 10. known history of a bleeding disorder of an inherited or active acquired bleeding disorder; 11. known history of heparin-induced thrombocytopenia; 12. known allergy to UFH or LMWH; 13. admitted to the intensive care unit at the time of screening; 14. treated with non-invasive positive pressure ventilation or invasive mechanical ventilation at the time of screening; 15. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
Herramientas de búsqueda: RSS